LIfT BioSciences N-LIfT Cell Therapy Successfully Infiltrates Pancreatic Tumours In-vivo
London, 9 November 2020 –LIfT BioSciences, a biotech company developing a first in class innate cell therapy with the potential to...
top of page
LATEST NEWS
- Jan 15, 2020
LIfT BioSciences secures a further round of funding for its game-changing innate cell therapy
London, 15th January 2020 – Biotech LIfT BioSciences today announced a further major investment into the company in its mission to...
- Feb 12, 2019
LIfT BioSciences signals a new dawn in Cancer Therapy at The Prostate Cancer Foundation Retreat
Alex Blyth, CEO of LIfT BioSciences, delivered the closing presentation for The 25th Prostate Cancer Foundation Retreat in Carlsbad, USA...
bottom of page